Antitrust
The Chamber advocates for antitrust laws that benefit all consumers and businesses and do not target specific companies or industries.
Latest
Featured story
With the trial phase of the United States v. Google case complete, the court must now focus on determining a remedy that addresses specific unfair practices without stifling competition.
Our Work
Antitrust laws ensure competition in free and open markets, which is the foundation of any vibrant, diverse, and dynamic economy. Healthy market competition benefits consumers through lower prices, higher quality products and services, more choices, and greater innovation.
Latest Content
This Hill letter was sent to Members of the United States Senate opposing S. 3197, the "Platform Competition and Opportunity Act of 2021." This bill is on the Legislative Leadership list for the “How They Voted” scorecard.
This Hill letter was sent to the Members of the United States Senate, opposing S. 2992, the "American Innovation and Choice Online Act." This bill is on the Legislative Leadership list for the “How They Voted” scorecard.
Washington, D.C. — U.S. Chamber Executive Vice President and Chief Policy Officer Neil Bradley issued the following statement today regarding the announcement of antitrust legislation expected to be introduced in the Senate next week:
This Coalition letter was sent to Members of the Senate and House Judiciary Committees on mergers and acquisitions.
The Chamber submitted comments to the Federal Trade Commission in response to its Solicitation for Public Comments on Contract Terms that May Harm Competition. These comments focus on non-compete clauses, in reference to a Petition for Rulemaking to Prohibit Worker Non-Compete Clauses.
The Chamber submitted comments to the Federal Trade Commission in response to its Solicitation for Public Comments on Contract Terms that May Harm Competition. These comments focus on exclusive contracts, in reference to a Petition for Rulemaking to Prohibit Exclusionary Contracts.
This Hill letter was sent to Members of the House Judiciary Committee on H.R. 2891, the “Preserve Access to Affordable Generics and Biosimilars Act,” H.R. 2873, the “Affordable Prescriptions for Patients Act Through Promoting Competition Act,” and H.R. 2884, the “Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act.”
This Hill letter was sent to Members of the Senate Judiciary Committee opposing S. 1787, the “State Antitrust Enforcement Venue Act of 2021.”
Key laws and terms to know about antitrust
What antitrust is and what it is not